Study supports allergy vaccine using genetically engineered pollen

08/10/2004 | Forbes

Researchers report the first-ever trial on an allergy vaccine developed from genetically engineered pollen shows promise in treating the condition by triggering a strong immune response in the body. The vaccine is seen as a replacement for immunotherapy, a common treatment for allergies that sometimes can make the problem worse.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC